NovaBay Total Current Liabilities from 2010 to 2025

NBY Stock  USD 0.61  0.01  1.61%   
NovaBay Pharmaceuticals Total Current Liabilities yearly trend continues to be fairly stable with very little volatility. Total Current Liabilities will likely drop to about 4.1 M in 2025. Total Current Liabilities is the total amount of liabilities that NovaBay Pharmaceuticals is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2005-12-31
Previous Quarter
3.6 M
Current Value
M
Quarterly Volatility
1.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 229.5 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many indicators such as Price To Sales Ratio of 0.0638, Dividend Yield of 0.0 or PTB Ratio of 0.28. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NovaBay Pharmaceuticals Correlation against competitors.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Latest NovaBay Pharmaceuticals' Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of NovaBay Pharmaceuticals over the last few years. Total Current Liabilities is an item on NovaBay Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NovaBay Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. NovaBay Pharmaceuticals' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

NovaBay Total Current Liabilities Regression Statistics

Arithmetic Mean3,786,832
Geometric Mean3,360,496
Coefficient Of Variation32.34
Mean Deviation867,478
Median4,097,616
Standard Deviation1,224,641
Sample Variance1.5T
Range5.4M
R-Value0.55
Mean Square Error1.1T
R-Squared0.30
Significance0.03
Slope141,677
Total Sum of Squares22.5T

NovaBay Total Current Liabilities History

20254.1 M
20244.9 M
20234.3 M
20224.3 M
20213.4 M
20202.8 M
20195.7 M

About NovaBay Pharmaceuticals Financial Statements

NovaBay Pharmaceuticals investors use historical fundamental indicators, such as NovaBay Pharmaceuticals' Total Current Liabilities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Liabilities4.9 M4.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.